# Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)

> **NCT04912609** · — · COMPLETED · sponsor: **IRCCS Fondazione Stella Maris** · enrollment: 13 (actual)

## Conditions studied

- Hereditary Spastic Paraplegia
- Spastic Paraplegia Type 11

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04912609
- **Lead sponsor:** IRCCS Fondazione Stella Maris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-30
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912609, "Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04912609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*